1-3 of 3
Gilberto Israel Barranco Lampon
Close
Sort by
Journal Articles

Efficacy of Bortezomib Combined with Hyper-CVAD in Adults with Relapsed Acute Lymphoblastic Leukemia or Positive Measurable Residual Disease

Christian Omar Ramos Peñafiel, Daniela Pérez Sámano, Adán Germán Gallardo-Rodríguez, Irma Olarte Carrillo, Camila Terreros Palacios, Carlos Martínez Murillo, Gilberto Israel Barranco Lampón, Álvaro Cabrera García, Humberto Baldemar Castellanos Sinco, Adolfo Martínez Tovar
Journal: Blood
Blood (2023) 142 (Supplement 1): 5904.
https://doi.org/10.1182/blood-2023-173061
Published: 2023
Journal Articles

Getting to Know the Molecular Landscape of R/R Chronic Myeloid Leukemia: NGS-Based Profiling of Myeloid Mutations Beyond BCR/ABL

Roberto Ovilla-Martínez, Pamela E Baez Islas, Carmen Alaez-Verson, Nishalle E Ramirez Muniz, Fernando Perez-Jacobo, Gabriel Barragan-Ibañez, Mercedes González, Jesus Manuel L Lopez Valles, Laura I Banda-García, Eduardo E. Reynoso, Gregorio Campos Cabrera, Uendy Perez-Lozano, Samanta Tingen Velarde, Yolanda Lugo-García, Ana Carolina Reynoso, Jose L. Alvarez, Hiram U Severino-Lugo, Gilberto Israel Barranco Lampón
Journal: Blood
Blood (2023) 142 (Supplement 1): 6361.
https://doi.org/10.1182/blood-2023-181162
Published: 2023
Journal Articles

Meter: A Multi-Country, Real-World Chart Review Study to Explore Treatment Patterns, Effectiveness and Healthcare Resource Utilization for Patients with Myelofibrosis

Vikas Gupta, Ciprian Tomuleasa, Gilberto Israel Barranco Lampon, Hsin-An Hou, Grzegorz Helbig, Argiris S. Symeonidis, Ibrahim Haznedaroglu, Kenny Galvez, Fernando Tatsch, Avijeet S Chopra, Meng Zhang, Tamas Vizkelety, David M Ross
Journal: Blood
Blood (2023) 142 (Supplement 1): 3205.
https://doi.org/10.1182/blood-2023-173942
Published: 2023